Fidelity Investments’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$22.8M Buy
+1,414,190
New +$22.8M ﹤0.01% 1656
2024
Q2
Sell
-1
Closed -$201 5475
2024
Q1
$201 Buy
+1
New +$201 ﹤0.01% 4914
2022
Q1
Sell
-10
Closed -$1K 5177
2021
Q4
$1K Buy
10
+3
+43% +$300 ﹤0.01% 4137
2021
Q3
$2K Hold
7
﹤0.01% 4012
2021
Q2
$2K Hold
7
﹤0.01% 3922
2021
Q1
$2K Hold
7
﹤0.01% 3718
2020
Q4
$3K Buy
+7
New +$3K ﹤0.01% 3520
2020
Q3
Sell
-6
Closed -$2K 3802
2020
Q2
$2K Buy
+6
New +$2K ﹤0.01% 3364
2020
Q1
Sell
-2
Closed -$1K 3866
2019
Q4
$1K Sell
2
-323
-99% -$162K ﹤0.01% 3646
2019
Q3
$140K Sell
325
-41,740
-99% -$18M ﹤0.01% 2689
2019
Q2
$50.1M Buy
42,065
+3,098
+8% +$3.69M 0.01% 1217
2019
Q1
$48.6M Buy
38,967
+3,651
+10% +$4.55M 0.01% 1231
2018
Q4
$33.4M Sell
35,316
-2,699
-7% -$2.56M ﹤0.01% 1336
2018
Q3
$54.7M Buy
38,015
+409
+1% +$589K 0.01% 1231
2018
Q2
$60.7M Buy
37,606
+2,900
+8% +$4.68M 0.01% 1186
2018
Q1
$56.3M Buy
34,706
+6,319
+22% +$10.3M 0.01% 1240
2017
Q4
$47.7M Buy
28,387
+13,584
+92% +$22.8M 0.01% 1322
2017
Q3
$20.7M Sell
14,803
-233
-2% -$326K ﹤0.01% 1683
2017
Q2
$16.8M Buy
+15,036
New +$16.8M ﹤0.01% 1751
2016
Q1
Sell
-1,492
Closed -$853K 2692
2015
Q4
$853K Buy
1,492
+99
+7% +$56.6K ﹤0.01% 2541
2015
Q3
$780K Buy
1,393
+1,268
+1,014% +$710K ﹤0.01% 2550
2015
Q2
$100K Buy
+125
New +$100K ﹤0.01% 2708